Last reviewed · How we verify
NCT04689243
Low Concentration ALA-PDT in Treatment of Skin Ulcer
NA trial testing ALA-PDT in Skin Ulcer in 28 participants. Status unknown.
26 December 2020
Quick facts
| Lead sponsor | Sichuan Provincial People's Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 1 January 2019 |
| Primary completion | 26 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- ALA-PDT
- red light
Conditions studied
- Skin Ulcer — all drugs for Skin Ulcer →
- Photodynamic Therapy — all drugs for Photodynamic Therapy →
Sponsor
Sichuan Provincial People's Hospital
Who can join
Eligibility, any sex, with Skin Ulcer or Photodynamic Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Skin ulcer is a common disease with complicated etiopathogenes, which makes it hard to be cured. It has been reported that photodynamic therapy (PDT) can be used to treat skin ulcers which were caused by different diseases. However, PDT is an expensive treatment and patients always experience obvious pain during or after the treatment, which hinders the application of PDT in skin ulcer. Our previous study found that PDT using a low concentration of 5-Aminolevulinic acid (ALA) could promote the healing of skin ulcer without obvious adverse reactions, which suggests us that low concentration ALA-PDT might be an efficient and cost effective treatment in skin ulcer. To further investigate the use of low concentration ALA-PDT in skin ulcer, we plan to recruit patients with skin ulcers caused by different diseases, and divide these patients into different groups according to their causes of disease, and then treat them using low concentration ALA-PDT to observe the healing process of skin ulcer. This study could further optimize and promote the use of low concentration ALA-PDT in skin ulcer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04689243
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ALA-PDT
Trials testing the same drug.
- NCT06982976 — Efficacy and Safety of Photodynamic Therapy for Cervical and Vaginal Intraepithelial Neoplasia · NA · recruiting
- NCT07009327 — Efficacy and Safety of Photodynamic Therapy for CIN3 · NA · recruiting
Other recruiting trials for Skin Ulcer
Currently open trials in the same condition.
- NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
Other Sichuan Provincial People's Hospital trials
Trials by the same sponsor.
- NCT07298525 — Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monito · Phase 4 · not yet recruiting
- NCT07175363 — Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study · not yet recruiting
- NCT07106996 — Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycysti · EARLY_PHASE1 · recruiting
- NCT07082946 — Mechanisms of Perioperative Systemic Inflammation in the Development of PND in Cirrhotic Patients · not yet recruiting
- NCT06821633 — Investigating the Retardation Effect of OCTA-Guided Targeted Photocoagulation on the Progression of Non-Perfusion Areas · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04689243 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sichuan Provincial People's Hospital
- Last refreshed: 30 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04689243.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing